News

New therapeutic possibilities for various diseases are made possible via mRNA. The adaptability of in vitro transcribed (IVT) mRNA is largely due to its simpler cell-free manufacture, cell cycle ...
As the first step in many workflows, in vitro transcription (IVT) has quickly emerged as an essential part of successful mRNA therapeutic manufacturing processes, optimizing and accelerating ...
Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...
Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA ...
A team of researchers led by Dr. KIM V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...
Enter Primrose Bio with its offering of commercially available, proprietary, best-in-class RNA polymerases for mRNA synthesis by in vitro transcription (IVT) (Fig. 1). Primrose Bio’s Prima ...
Fintel reports that on March 20, 2025, Wolfe Research initiated coverage of InvenTrust Properties (NYSE:IVT) with a Peer Perform recommendation. As of March 19, 2025, the average one-year price ...
Southern RNA is an Australian CDMO specialising in producing nucleic acid products that support the clinical development of ...
Shorrock outlined plans to monetize demand for GMP IVT templates, targeting revenues ... the GMP manufacturing capacity to meet demand from mRNA therapeutics developers and CDMOs, with contracts ...